1 Min Read
May 25 (Reuters) - Glycomimetics Inc
* Glycomimetics’ GMI-1271 receives EU orphan drug designation for acute myeloid leukemia Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.